Wedbush analyst Liana Moussatos reiterated a Buy rating on Global Blood Therapeutics (GBT – Research Report) today and set a
Tag: GBT
H.C. Wainwright Believes Global Blood Therapeutics (NASDAQ: GBT) Still Has Room to Grow
In a report released today, Debjit Chattopadhyay from H.C. Wainwright reiterated a Buy rating on Global Blood Therapeutics (GBT –
Oppenheimer Believes Global Blood Therapeutics (NASDAQ: GBT) Won’t Stop Here
Oppenheimer analyst Mark Breidenbach maintained a Buy rating on Global Blood Therapeutics (GBT – Research Report) today and set a
Analysts Offer Insights on Healthcare Companies: Global Blood Therapeutics (NASDAQ: GBT) and Revance Therapeutics (NASDAQ: RVNC)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Global Blood
Wedbush Sticks to Its Buy Rating for Global Blood Therapeutics (GBT)
Wedbush analyst Liana Moussatos reiterated a Buy rating on Global Blood Therapeutics (GBT – Research Report) today and set a
Oppenheimer Sticks to Their Buy Rating for Global Blood Therapeutics (GBT)
In a report released today, Mark Breidenbach from Oppenheimer maintained a Buy rating on Global Blood Therapeutics (GBT – Research
Global Blood Therapeutics (GBT) Gets a Buy Rating from Cowen & Co.
Cowen & Co. analyst Ritu Baral maintained a Buy rating on Global Blood Therapeutics (GBT – Research Report) today and